AJP - Heart Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 289: H2073-H2080, 2005. First published June 24, 2005; doi:10.1152/ajpheart.01216.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/5/H2073    most recent
01216.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chao, W.
Right arrow Articles by Rosenzweig, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chao, W.
Right arrow Articles by Rosenzweig, A.

Fas-associated death-domain protein inhibits TNF-{alpha} mediated NF-{kappa}B activation in cardiomyocytes

Wei Chao,1,2,* Yan Shen,1,2,* Ling Li,1 Huailong Zhao,2 Steffen E. Meiler,4 Stuart A. Cook,1 and Anthony Rosenzweig1,3

1Program in Cardiovascular Gene Therapy, Cardiovascular Research Center, Massachusetts General Hospital, Charlestown; 2Department of Anesthesia and Critical Care, and 3Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and 4Department of Anesthesia, Medical College of Georgia, Augusta, Georgia

Submitted 6 December 2004 ; accepted in final form 3 June 2005

Fas-associated death-domain protein (FADD) is an adaptor molecule that links death receptors to caspase-8 in many cell types including cardiomyocytes (CMs). Although FADD has previously been reported to play an important role in CM apoptosis, the effect of FADD on CM NF-{kappa}B signaling, which is a proinflammatory pathway, has not been delineated. To investigate the role of FADD in CM NF-{kappa}B activation, we utilized adenoviral gene transfer of wild-type FADD and a truncation mutant that lacks the death-effector domain (FADD-DED) in rat CMs in vitro TNF-{alpha} activated NF-{kappa}B in CMs as demonstrated by phosphorylation and degradation of inhibitory-{kappa}B (I{kappa}B)-{alpha}-enhanced nuclear p65 and NF-{kappa}B DNA-binding activity as well as increased mRNA for the NF-{kappa}B-dependent adhesion molecule VCAM-1 (19 ± 4.1-fold) as measured by quantitative RT-PCR. Gene transfer of FADD inhibited TNF-{alpha}-induced I{kappa}B-{alpha} phosphorylation, decreased p65 nuclear translocation and NF-{kappa}B DNA-binding activity, and reduced VCAM-1 transcript levels by 53–65%. Interestingly, FADD-DED exhibited a similar but weaker inhibitory effect on NF-{kappa}B activation. The effects of FADD on NF-{kappa}B were cell-type specific. FADD expression also inhibited TNF-{alpha}-mediated NF-{kappa}B activation in human endothelial cells but not in rat pulmonary artery smooth muscle cells. In contrast, FADD expression actually activated NF-{kappa}B in human embryonic kidney (HEK)-293 cells. In CMs, FADD inhibited NF-{kappa}B activation as well as phosphorylation of I{kappa}B-{alpha} and I{kappa}B kinase (IKK)-{beta} in response to cytokine stimulation or expression of the upstream kinases NF-{kappa}B-inducing kinase and IKK-{beta}. These data demonstrate that FADD inhibits NF-{kappa}B activation in CMs, and this inhibition likely occurs at the level of phosphorylation and activation of IKK-{beta}.

signal transduction; cardiac; inflammation; tumor necrosis factor; nuclear factor-{kappa}B



Address for reprint requests and other correspondence: A. Rosenzweig, MGH-EAST, 114 16th St., Rm. 2600, Charlestown, MA 02129 (E-mail: arosenzweig{at}partners.org)




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. H. Li, A. D'Alessio, and J. S. Pober
Lipopolysaccharide Can Trigger a Cathepsin B-Dependent Programmed Death Response in Human Endothelial Cells
Am. J. Pathol., September 1, 2009; 175(3): 1124 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Chakraborty, H. Brooks, P. Zhang, W. Smith, M. R. McReynolds, J. B. Hoying, R. Bick, L. Truong, B. Poindexter, H. Lan, et al.
Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F895 - F904.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.